Position in INSM
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$40,955,940
+$4,283,147 QoQ
Shares Held
384,130
+71.3% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
6.79%
of 13F equity value
Holder Rank
#90
of 665 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eagle Health Investments LP holds $387,533,407 across 16 Biotechnology names. INSM ranks #2 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
76,417 | $70,897,400 | |
| 2 | INSM |
INSMED Inc
This page
|
384,130 | $40,955,940 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
624,676 | $35,743,960 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
555,272 | $30,539,960 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
248,322 | $30,439,310 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
884,121 | $29,520,800 | |
| 7 | ASND |
Ascendis Pharma A/S
|
106,158 | $28,314,461 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
120,346 | $22,538,398 |
All Filings in INSM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,955,940 | 384,130 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $36,672,793 | 224,271 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $36,705,036 | 210,900 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $39,113,116 | 271,600 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $43,134,304 | 428,600 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $33,819,357 | 443,300 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $35,465,848 | 513,700 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $37,500,100 | 513,700 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $34,417,900 | 513,700 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||